Natco Pharma Ltd

NSE: NATCOPHARM · BSE: 524816 · Pharmaceuticals & Biotechnology · 18 announcements

Share price: ₹839.30
Market cap: ₹15,033 Cr
Revenue (annual): ₹4,078 Cr
Net profit (annual): ₹1,418 Cr
P/E (TTM): 13.1×Sector 50.4×
Promoter holding: 49.42%+0.00% QoQ
FII holding: 16.99%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 3 Capital Structure Change 3 Fund Raise 2 Board Meeting Date 2 Other Announcement 1 Financial Results 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

25 Sep 2026 11:33 IST BSE

Fund RaiseAlfa Alert

Natco Pharma Fund Raise of ₹1,279 Cr

Natco Pharma's board has approved a Rights Issue to raise ₹1,279.36 Crore. The company will issue 17,058,082 equity shares at ₹750 each in a 2:21 ratio.

Value: ₹1,279 Cr

Read the filing ↗

9 Sep 2026 11:47 IST BSE

Fund RaiseAlfa Alert

Natco Pharma Fund Raise of ₹1,300 Cr

Natco Pharma board approved a rights issue of up to ₹1,300 crore face value ₹2 equity shares. The demerger scheme will be revised post-completion of the raise.

Value: ₹1,300 Cr

Read the story on ALFA News Read the filing ↗